Tag: CLF

Blue Horseshoe Stocks: BCLI Recap & More

BrainStorm Cell Therapeutics, Inc. BCLI

2015 is upon us and our first order of business is to address one of the stocks we tagged in Wednesday’s premarket report. BCLI had a strong session, as it pushed its way up from an early low of 4.02 to an aftyernoon high of 4.94; a solid +23% performance.

The strong session was apparently aided by the pre-emptive PR the company released which served as a reminder that results from Phase 2a trials of its ALS (Lou Gehrig’s Disease) treatment would be released on Monday. This morning the stock is gapping up wildly as anticipation grows, having already hit a premarket high of 7.28, which represents a total increase of 81% over the low we observed on New Year’s Eve.

Monday’s data release, which is expected to be positive, should most likely produce one of two effects. Either the results will beat expectations and facilitate another strong move, or they will fail to meet the mark and cause a pullback. In case of the latter, there may be rebound opportunities waiting just around the corner.


RedHill BioPharma Ltd. RDHL & NephroGenex, Inc. NRX

We also had this pair of standouts appear in Wednesday’s report, with each stock making a similar move. Both started the day with significant spikes in PPS, followed by a tapering off into the close.

RDHL made a sensational jump beginning almost immediately at the open running from 12.52 on up to 17.85 before its pullback, an intraday spike equaling 42.5%. Coincidentally, the stock ended the session having traded 42.5X its 3-month average volume.

NRX saw an initial low of 12.96, followed by a healthy 39% run to a high of 17.98. This play would offer one more opportunity in the form of an intraday swing as it came down and rebounded off of the 12.60-mark before returning to 15.15, an added 20% move, bringing the day’s cumulative total of possible gains to 59% .

Extended Watchlist:
CUR, ARWR, CLF, MSTX, RAD

Blue Horseshoe Stocks: PZOO Update, Commenting on the Marijuana Sector

Pazoo, Inc. PZOO

So far we’ve been very happy with the way PZOO has performed since we brought it into the mix to start the week. Our assertion that the PZOO chart was on the cusp of making a nice move proved accurate; after starting out at a low of .0225 on Monday, the stock broke through its 50DMA and traded as high as .031 during yesterday’s session (+38%).

Volume picked up as well, with the stock trading 2.6M shares on the day, which works out to more than 3.5X the 3-month average.

So this new play that has us interested on a long-term basis (for reasons stated in our initial report) has also shown that it has some real short-term potential as well. We also caught a fresh PR this morning, which you’ll find below the following snapshot of the PZOO chart:

WHIPPANY, NJ–(Marketwired – Oct 22, 2014) – Pazoo, Inc. (OTCQB: PZOO) (German WKN#: A1J3DK) is pleased to announce its medical marijuana testing laboratory partner MA & Associates, LLC has hired its first lab technician, Mr. Brad Gore. Further, the build-out for the testing facility began last week. Now that the asbestos abatement was done, actual construction to the facility will begin.

MA & Associates, LLC felt it necessary to begin the build-out of the testing facility and to begin hiring all necessary personnel prior to the State of Nevada issuing licenses to qualified applicants on November 3rd >> FULL PR

PZOO is dually involved with the continued development of its health and wellness online portal at PAZOO.COM as well as its majority stake in a medical marijuana testing firm in Nevada. For those who might have missed our special report on the stock Monday, you can find a copy here: PZOO REPORT

Marijuana Sector Reminder

We also want to touch briefly on our ongoing interest in other medical and legal marijuana plays. For over two years we’ve tracked, and continue to monitor the sector as a whole, with huge winners coming in the form of MJNA, CBIS, HEMP, GRNH, TRTC, ERBB, and so many others.

We recently reminded everyone that we’d be on the lookout for the cannabis space to heat up as we approach a voting season with an unprecedented number of marijuana initiatives on ballots across the country.

This Monday, a federal court will hear evidence contesting that the US Government’s classification of marijuana as a Schedule 1 substance (which ridiculously makes it equal to heroin in the eyes of federal law) is unfounded. Several doctors are prepared to challenge the scientific and medical validity of government claims. If truth and reason win the day, it could be a big step toward  furthering the cause of cannabis acceptance nationwide. >>> READ ARTICLE

Extended Watchlist:
IBIO, RGLS, CLF, BBLU, ZAZA

Blue Horseshoe Stocks: MYEC, MEDT, CLF Options

Good Morning Traders, we hope everyone had an enjoyable long weekend! We are more than ready to get back down to business today. Let us start off by congratulating ourselves for a job well done. Thursday’s mention of EXMT landed us a spot of Penny Stock Rumble’s top gainers list.

We are bringing you two sub-penny picks this morning that we feel have a chance to do as well, if not better than EXMT.

___

MyECheck, Inc. MYEC

MYEC got pushed down in March from .035, gapping down to sub-penny prices, where it is currently. We always scan for opportunities such as this, when a play like MYEC begins to recover from such a backslide. On Thursday, the play set off our bounce alarm, and we are extremely anxious to see how the momentum it built carries over into this new week.The chart below shows the recent history of MYEC. We can see that the stock traded very little leading up to the month of March, and all of the sudden, in a surge of volume, it gets taken off of a cliff. We definitely want to exercise caution with MYEC, while at the same time hoping to hitch a ride as this stock gradually begins to build back its PPS. The past few trading sessions have seen higher lows and higher highs, so MYEC starts this week as one of the stocks near the top of our watchlist.

___

MediaTechnics Corp. MEDT

MEDT is another sub-penny prospect that we are looking at this morning. It set off our scanner on Thursday, trading abnormally high volume, and making a tremendous surge to the upside. We are looking at two key levels of resistance at present, at Thursday’s high of .0019, and a recent swing high of .0022.Any time this kind of activity shows up, you can bet that we are paying close attention.

MEDT has also had its hands in the medical marijuana sector, recently releasing a PR that outlined the company’s plans to sell $500,000 in LED grow lights to Evergreen Systems Incorporated over the next year. That places MEDT in the ever-growing group of cannabis-related stocks that we are tracking.

___

Cliffs Natural Resources Inc. CLF – Options Trading

This is a big-board stock that recently saw a gap-down. Already up 3% in pre-market trading today, we are categorizing CLF as a recovery play. We’d like to see it return to the 21-22.00 range. Right now, we are paying close attention to the 19.50 Calls, which closed at .31 on Thursday. Should the stock return to the previous levels mentioned, these calls could be trading in the 1.50-2.50 range.
___